Reviews
Cloned adenosine A3 receptors: Pharmacological properties, species differences and receptor functions

https://doi.org/10.1016/0165-6147(94)90011-6Get rights and content

Abstract

In this review, Joel Linden summarizes what is known about a new and intriguing member of the adenosine receptor family, the A3 receptor. This receptor exhibits unusually large differences in structure, tissue distribution and pharmacological properties between species. Rat A3 receptors are resistant to blockade by xanthine antagonists, but human and sheep A3 receptors can be potently blocked by certain xanthines, notably acidic 8-phenylxanthines. One function of the receptor is to facilitate degradation of mast cells, and a role for mast cells and A3 receptors in mediating myocardial preconditioning has been proposed. Therefore, selective antagonists of A3 receptors have potential for the treatment of allergic, inflammatory and possibly ischaemic disorders.

References (38)

  • W. Meyerhof et al.

    FEBS Lett.

    (1991)
  • F.G. Sajjadi et al.

    Biochem. Biophys. Acta Mol. Cell Res.

    (1993)
  • M.K. Church et al.

    J. Allergy Clin. Immunol.

    (1993)
  • V. Ramkumar et al.

    J. Biol. Chem.

    (1993)
  • K.A. Jacobson

    FEBS Lett.

    (1993)
  • A.M. Carruthers et al.

    Eur. J. Pharmacol.

    (1993)
  • J. Linden et al.

    Trends Pharmacol. Sci.

    (1991)
  • J.L. Boyer et al.

    J. Biol. Chem.

    (1994)
  • B.F. O'Dowd

    J. Biol. Chem.

    (1988)
  • B.F. O'Dowd et al.

    J. Biol. Chem.

    (1989)
  • J.A. Ribeiro et al.

    Prog. Neurobiol.

    (1986)
  • J.A. Ribeiro et al.

    Trends Pharmacol. Sci.

    (1994)
  • A.M. Carruthers et al.

    Trends Pharmacol Sci.

    (1993)
  • D. Ukena

    FEBS Lett.

    (1986)
  • A.L. Tucker et al.

    FEBS Lett.

    (1992)
  • D. Ukena

    FEBS Lett.

    (1986)
  • A.I. Tucker et al.

    Cardiovasc. Res.

    (1993)
  • Q-Y. Zhou
  • H. Heithier

    Eur. J. Biochem.

    (1992)
  • Cited by (382)

    • Adenosine and its receptors as therapeutic targets: An overview

      2013, Saudi Pharmaceutical Journal
      Citation Excerpt :

      It has also been shown to stimulate directly phospholipases C and D. A3 receptor activation also results in the influx of calcium and its release from intracellular stores (Jacobson, 1998). The A3 receptor usually exhibits large differences in structure, tissue distribution and its functional and pharmacological properties between species (Linden, 1994). A3 mediated degranulation of mast cells or enhancement of allergen induced mast cell degranulation may be important in animal models of allergic responses.

    • Selective and potent adenosine A<inf>3</inf> receptor antagonists by methoxyaryl substitution on the N-(2,6-diarylpyrimidin-4-yl)acetamide scaffold

      2013, European Journal of Medicinal Chemistry
      Citation Excerpt :

      Among the ARs, A3ARs are the latest cloned and pharmacologically characterized. The A3AR is involved in a variety of important physiological processes, including modulation of cerebral and cardiac ischemic damage [4,5], inflammation [6], modulation of intraocular pressure [7], regulation of normal and tumor cell growth [8,9] and immunosuppression [10]. However, A3-signaling in several processes is still controversial [11,12], being perhaps the most enigmatic among adenosine receptors.

    View all citing articles on Scopus
    View full text